18 results on '"Buran, B."'
Search Results
2. A Sensitive Period for the Impact of Hearing Loss on Auditory Perception
- Author
-
Buran, B. N., primary, Sarro, E. C., additional, Manno, F. A. M., additional, Kang, R., additional, Caras, M. L., additional, and Sanes, D. H., additional
- Published
- 2014
- Full Text
- View/download PDF
3. Considering sustainability in the planning of transit systems: Istanbul case
- Author
-
Buran, B., primary and Feyzioğlu, O., additional
- Published
- 2013
- Full Text
- View/download PDF
4. Onset Coding Is Degraded in Auditory Nerve Fibers from Mutant Mice Lacking Synaptic Ribbons
- Author
-
Buran, B. N., primary, Strenzke, N., additional, Neef, A., additional, Gundelfinger, E. D., additional, Moser, T., additional, and Liberman, M. C., additional
- Published
- 2010
- Full Text
- View/download PDF
5. Erste klinische Erfahrungen mit der Koronarendoskopie
- Author
-
Hombach, V., primary, Höher, M., additional, Hannekum, A., additional, Hügel, W., additional, Buran, B., additional, Höpp, H. W., additional, and Hirche, Hj., additional
- Published
- 2008
- Full Text
- View/download PDF
6. Environmental benefits of implementing alternative energy technologies in developing countries
- Author
-
Buran, B, primary, Butler, L, additional, Currano, A, additional, Smith, E, additional, Tung, W, additional, Cleveland, K, additional, Buxton, C, additional, Lam, D, additional, Obler, T, additional, Rais-Bahrami, S, additional, Stryker, M, additional, and Herold, K, additional
- Published
- 2003
- Full Text
- View/download PDF
7. Glycosylphosphatidylinositol anchor biosynthesis pathway-based biomarker identification with machine learning for prognosis and T cell exhaustion status prediction in breast cancer.
- Author
-
Wu H, Wu Z, Li H, Wang Z, Chen Y, Bao J, Chen B, Xu S, Xia E, Ye D, and Dai X
- Subjects
- Humans, Female, Prognosis, CD8-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes metabolism, Lymphocytes, Tumor-Infiltrating immunology, Lymphocytes, Tumor-Infiltrating metabolism, T-Cell Exhaustion, Breast Neoplasms immunology, Breast Neoplasms diagnosis, Breast Neoplasms metabolism, Breast Neoplasms mortality, Glycosylphosphatidylinositols metabolism, Biomarkers, Tumor, Machine Learning, Tumor Microenvironment immunology
- Abstract
As the primary component of anti-tumor immunity, T cells are prone to exhaustion and dysfunction in the tumor microenvironment (TME). A thorough understanding of T cell exhaustion (TEX) in the TME is crucial for effectively addressing TEX in clinical settings and promoting the efficacy of immune checkpoint blockade therapies. In eukaryotes, numerous cell surface proteins are tethered to the plasma membrane via Glycosylphosphatidylinositol (GPI) anchors, which play a crucial role in facilitating the proper translocation of membrane proteins. However, the available evidence is insufficient to support any additional functional involvement of GPI anchors. Here, we investigate the signature of GPI-anchor biosynthesis in the TME of breast cancer (BC)patients, particularly its correlation with TEX. GPI-anchor biosynthesis should be considered as a prognostic risk factor for BC. Patients with high GPI-anchor biosynthesis showed more severe TEX. And the levels of GPI-anchor biosynthesis in exhausted CD8 T cells was higher than normal CD8 T cells, which was not observed between malignant epithelial cells and normal mammary epithelial cells. In addition, we also found that GPI -anchor biosynthesis related genes can be used to diagnose TEX status and predict prognosis in BC patients, both the TEX diagnostic model and the prognostic model showed good AUC values. Finally, we confirmed our findings in cells and clinical samples. Knockdown of PIGU gene expression significantly reduced the proliferation rate of MDA-MB-231 and MCF-7 cell lines. Immunofluorescence results from clinical samples showed reduced aggregation of CD8 T cells in tissues with high expression of GPAA1 and PIGU., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Wu, Wu, Li, Wang, Chen, Bao, Chen, Xu, Xia, Ye and Dai.)
- Published
- 2024
- Full Text
- View/download PDF
8. Attention guided neural ODE network for breast tumor segmentation in medical images.
- Author
-
Ru J, Lu B, Chen B, Shi J, Chen G, Wang M, Pan Z, Lin Y, Gao Z, Zhou J, Liu X, and Zhang C
- Subjects
- Female, Humans, Animals, Breast, Neural Networks, Computer, Image Processing, Computer-Assisted, Mammary Neoplasms, Animal, Breast Neoplasms diagnostic imaging
- Abstract
Breast cancer is the most common cancer in women. Ultrasound is a widely used screening tool for its portability and easy operation, and DCE-MRI can highlight the lesions more clearly and reveal the characteristics of tumors. They are both noninvasive and nonradiative for assessment of breast cancer. Doctors make diagnoses and further instructions through the sizes, shapes and textures of the breast masses showed on medical images, so automatic tumor segmentation via deep neural networks can to some extent assist doctors. Compared to some challenges which the popular deep neural networks have faced, such as large amounts of parameters, lack of interpretability, overfitting problem, etc., we propose a segmentation network named Att-U-Node which uses attention modules to guide a neural ODE-based framework, trying to alleviate the problems mentioned above. Specifically, the network uses ODE blocks to make up an encoder-decoder structure, feature modeling by neural ODE is completed at each level. Besides, we propose to use an attention module to calculate the coefficient and generate a much refined attention feature for skip connection. Three public available breast ultrasound image datasets (i.e. BUSI, BUS and OASBUD) and a private breast DCE-MRI dataset are used to assess the efficiency of the proposed model, besides, we upgrade the model to 3D for tumor segmentation with the data selected from Public QIN Breast DCE-MRI. The experiments show that the proposed model achieves competitive results compared with the related methods while mitigates the common problems of deep neural networks., Competing Interests: Declaration of competing interest The authors have declared no conflict of interest., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
9. S100A6 promotes the development of thyroid cancer and inhibits apoptosis of thyroid cancer cells through the PI3K/AKT/mTOR pathway.
- Author
-
Chen B, Zheng D, Liu C, Bhandari A, Hirachan S, Shen C, Mainali S, Li H, Jiang W, Xu J, Zhang X, Tang K, and Zhang W
- Subjects
- Humans, Apoptosis genetics, Cell Cycle Proteins metabolism, Cell Line, Tumor, Cell Movement, Cell Proliferation, Phosphatidylinositol 3-Kinases metabolism, Proto-Oncogene Proteins c-akt metabolism, TOR Serine-Threonine Kinases metabolism, S100 Calcium Binding Protein A6, Thyroid Neoplasms genetics
- Abstract
High levels of S100A6 have been associated with progression in some types of human cancers. Cancers related to S100A6 have been reported to include lung cancer, cervical cancer, pancreatic cancer, gastric cancer, colon cancer, etc., but its role in the molecular pathogenesis of these cancers is largely unknown. This study investigated the expression and functional roles of S100A6 in human thyroid cancer. The expression level of S100A6 in thyroid cancer cells was determined by bioinformatics and transcriptomic analysis. Furthermore, the potential functions of S100A6 in tumorigenesis were analyzed by cell proliferation, migration, invasion, and Western blot assays in human thyroid cancer cells. Public database queries revealed high S100A6 expression in thyroid cancer. In addition, we also found that high expression of S100A6 was positively correlated with malignant clinicopathological characteristics of thyroid cancer in The Cancer Genome Atlas database. qPCR results confirmed the high expression of S100A6 in thyroid cancer cells. S100A6 silencing inhibited cell proliferation, migration, and invasion. Western blot assays and response experiments showed that S100A6 promotes cell proliferation and tumorigenicity partly through the PI3K/AKT/mTOR signaling pathway. These results suggest that S100A6 affects the progression of thyroid cancer and can be used as a target in the future treatment of thyroid cancer., Competing Interests: Conflict of interest statement The authors declare that they have no conflict of interest., (Copyright © 2023 Elsevier GmbH. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
10. PDZK1IP1 gene promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
- Author
-
Zhang W, Zheng D, Jin L, Hirachan S, Bhandari A, Li Y, Chen B, Lu Y, Wen J, Lin B, Zhang X, and Chen C
- Abstract
Thyroid cancer is a common malignant tumor for the adult and the potential molecular mechanism of papillary thyroid cancer cell metastasis is still unclear. We used sequencing techniques to analyze paired papillary thyroid carcinoma (PTC) and adjacent thyroid tissue and identified a gene, PDZK1IP1, that was significantly overexpressed in thyroid cancer. We found It has been detected to play an important role in many malignant tumors. But the role in papillary thyroid cancer was still unknown, we decided to find a new marker and therapeutic target for the disease. The present study shows that PDZK1IP1 may be a potential gene that leads to thyroid cancer. In our study, silencing PDZK1IP1 can inhibit PTC cell proliferation, migration, invasion, apoptosis, and cell cycle arrest. This study surmised that PDZK1IP1 was an oncogene that correlated with tumor development., Competing Interests: Conflict of interest statement The authors declare that they have no conflict of interest., (Copyright © 2022 Elsevier GmbH. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
11. The ETNK2 gene promotes progression of papillary thyroid carcinoma through the HIPPO pathway.
- Author
-
Zheng D, Jin L, Chen B, Qi Y, Bhandari A, Wen J, Lin B, Zhang X, and Zhang W
- Abstract
Thyroid cancer is a disease with an extremely high incidence rate and is divided into papillary, follicular, medullary, and undifferentiated thyroid cancers. Among them, papillary carcinoma is the most common subtype. We assessed expression of ETNK2 in public databases and found that ETNK2 is upregulated in PTC. Cohort and RNA sequencing data were used to verify this discovery. To further determine the relationship between ETNK2 and papillary thyroid carcinoma, we performed an in vitro experiment. In a PTC cell line, silencing ETNK2 inhibited cell proliferation, weakened cell migration and invasion ability, promoted apoptosis, and blocked the cell cycle. In addition, western blotting suggested that ETNK2 is related to the HIPPO pathway and may activate the EMT pathway through the HIPPO pathway to promote the development of thyroid cancer. These results revealed that ETNK2 is related to the occurrence and development of papillary thyroid carcinoma, suggesting that ETNK2 may be an oncogene associated with PTC., Competing Interests: Competing Interests: The authors have declared that no competing interest exists., (© The author(s).)
- Published
- 2022
- Full Text
- View/download PDF
12. Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma.
- Author
-
Dong X, Song J, Chen B, Qi Y, Jiang W, Li H, Zheng D, Wang Y, Zhang X, and Liu H
- Abstract
B and T lymphocyte attenuator (BTLA) is a newly identified immune checkpoint molecular belonging to the CD28 immunoglobulin superfamily. However, the expression and clinical value of BTLA in skin cutaneous melanoma (SKCM) has not been widely characterized. We found that BTLA levels were upregulated in metastatic melanoma compared to normal skin tissues and primary melanoma. Higher BTLA was also correlated with improved prognosis in SKCM based on several datasets. The multivariate Cox regression model revealed that BTLA was an independent survival indicator in metastatic melanoma. Tumor microenvironment analysis indicated BTLA was positively associated with the infiltrating levels of different immune cells and the activity of the anti-cancer immunity cycle. Importantly, BTLA accurately predicted the outcome of melanoma patients treated with MAGE-A3 blocker or first-line anti-PD-1. The present findings disclose that BTLA is a reliable biomarker for prognosis and immunotherapeutic response and might contribute to developing novel SKCM immunological treatment strategies., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Dong, Song, Chen, Qi, Jiang, Li, Zheng, Wang, Zhang and Liu.)
- Published
- 2021
- Full Text
- View/download PDF
13. Revealing the selective mechanisms of inhibitors to PARP-1 and PARP-2 via multiple computational methods.
- Author
-
Hu H, Chen B, Zheng D, and Huang G
- Abstract
Background: Research has shown that Poly-ADP-ribose polymerases 1 (PARP-1) is a potential therapeutic target in the clinical treatment of breast cancer. An increasing number of studies have focused on the development of highly selective inhibitors that target PARP-1 over PARP-2, its closest isoform, to mitigate potential side effects. However, due to the highly conserved and similar binding sites of PARP-1 and PARP-2, there is a huge challenge for the discovery and design of PARP-1 inhibitors. Recently, it was reported that a potent PARP-1 inhibitor named NMS-P118 exhibited greater selectivity to PARP-1 over PARP-2 compared with a previously reported drug (Niraparib). However, the mechanisms underlying the effect of this inhibitor remains unclear., Methods: In the present study, classical molecular dynamics (MD) simulations and accelerated molecular dynamics (aMD) simulations combined with structural and energetic analysis were used to investigate the structural dynamics and selective mechanisms of PARP-1 and PARP-2 that are bound to NMS-P118 and Niraparib with distinct selectivity., Results: The results from classical MD simulations indicated that the selectivity of inhibitors may be controlled by electrostatic interactions, which were mainly due to the residues of Gln-322, Ser-328, Glu-335, and Tyr-455 in helix αF. The energetic differences were corroborated by the results from aMD simulations., Conclusion: This study provides new insights about how inhibitors specifically bind to PARP-1 over PARP-2, which may help facilitate the design of highly selective PARP-1 inhibitors in the future., Competing Interests: The authors declare there are no competing interests., (©2020 Hu et al.)
- Published
- 2020
- Full Text
- View/download PDF
14. Analyzing nanoparticle-induced neurotoxicity: A bibliometric analysis.
- Author
-
Wei X, Yang F, Chen D, Li J, Shi X, Li B, and Zhang C
- Subjects
- Amyloid beta-Peptides biosynthesis, Astrocytes drug effects, Humans, Inflammation chemically induced, Oxidative Stress physiology, United States, Bibliometrics, Nanoparticles toxicity, Neurotoxicity Syndromes epidemiology
- Abstract
Background: In recent years, nanoparticles have been widely used in many fields, ranging from cosmetics, agriculture, environment, and biomedical areas. The increasing use of nanoproducts induces a potential increasing exposure to human body, and then, unknown pathological consequences could increase., Methods: The database was searched from 2008 to 2018 by the Web of Science Core Collection. The bibliometric methods, CiteSpace and HistCite, were used for analysis and visualization of the data., Results: The 2932 publications were analyzed and the annual publications grew from 78 to 512 in a decade. The United States and China mainly contribute to this research area, which accounted for 29.5% and 22.9%, respectively. PLoS One , Scientific Reports , and Nanoscale were the three journals that published the most articles. Keyword analysis indicated that the major research direction was the mechanisms of nanoneurotoxicity, which included oxidative stress, inflammation, astrocyte activation, and the fibrillation of amyloid β protein., Conclusion: This bibliometric study revealed that nanoneurotoxicity was still a research hot topic and could be a promising area of research in the next few years. Nanoparticles play a role in neurodegenerative diseases by inducing reactive oxygen species production, inflammation, alterations of gene expression, and signal pathways.
- Published
- 2020
- Full Text
- View/download PDF
15. LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1.
- Author
-
Wang Y, Kurdi-Haidar B, and Oram JF
- Subjects
- ATP Binding Cassette Transporter 1, ATP-Binding Cassette Transporters antagonists & inhibitors, ATP-Binding Cassette Transporters chemistry, ATP-Binding Cassette Transporters immunology, Animals, Calpain antagonists & inhibitors, Cell Line, DNA-Binding Proteins, Enzyme Activation drug effects, Fatty Acids, Unsaturated pharmacology, Linoleic Acid, Liver X Receptors, Macrophages drug effects, Mice, Orphan Nuclear Receptors, Palmitates pharmacology, ATP-Binding Cassette Transporters metabolism, Fatty Acids, Unsaturated biosynthesis, Macrophages enzymology, Receptors, Cytoplasmic and Nuclear metabolism, Stearoyl-CoA Desaturase metabolism
- Abstract
Abnormal HDL metabolism among patients with diabetes and insulin resistance may contribute to their increased risk of atherosclerosis. ATP binding cassette transporter A1 (ABCA1) mediates the transport of cholesterol and phospholipids from cells to HDL apolipoproteins and thus modulates HDL levels and atherogenesis. Because fatty acids are increased in diabetes, we examined their effects on ABCA1 activity in cultured macrophages. cAMP analogs and ligands for the liver X receptor/retinoid X receptor (LXR/RXR) system can induce Abca1 transcription in murine macrophages. When induced by cAMP, unsaturated but not saturated long-chain fatty acids inhibit apolipoprotein-mediated lipid efflux by destabilizing ABCA1 protein. Here, we show that the saturated fatty acids palmitate and stearate also destabilize ABCA1 when Abca1 is induced by LXR/RXR ligands instead of cAMP. This was associated with increased palmitate and stearate desaturation by stearoyl-CoA desaturase (SCD), another gene product induced by LXR/RXR ligands. The SCD inhibitors conjugated linoleic acid and troglitazone nearly abolished ABCA1 destabilization by palmitate and stearate but not by linoleate. These results suggest that LXR/RXR ligands generate ABCA1-destabilizing monounsaturated fatty acids from their saturated precursors by activating SCD. Thus, with cholesterol-loaded macrophages exposed to saturated fatty acids, activated LXR/RXR may counteract the enhanced ABCA1 transcription by reducing the ABCA1 protein content.
- Published
- 2004
- Full Text
- View/download PDF
16. Identification of transdominant-negative genetic suppressor elements derived from hMSH2 that mediate resistance to 6-thioguanine.
- Author
-
de las Alas MM, Los G, Lin X, Kurdi-Haidar B, Manorek G, and Howell SB
- Subjects
- Amino Acid Sequence, Animals, Cell Division drug effects, Humans, Mice, Models, Molecular, Molecular Sequence Data, MutS Homolog 2 Protein, Proto-Oncogene Proteins physiology, Sequence Homology, Amino Acid, Tumor Cells, Cultured, Antimetabolites, Antineoplastic pharmacology, DNA-Binding Proteins, Drug Resistance, Neoplasm genetics, Proto-Oncogene Proteins genetics, Thioguanine pharmacology
- Abstract
Using random screening for genetic suppressor elements, we sought to identify portions of hMSH2 important to the ability of the mismatch repair system to recognize and process DNA adducts that mimic mismatches. All recovered candidate genetic suppressor elements were derived from the region containing amino acids 782 to 844. Expression of a peptide corresponding to this region partially disabled mismatch repair as evidenced by 1.5- to 3.3-fold resistance to 6-thioguanine, cisplatin, and N-methyl-N'-nitrosoguanidine, an increase in the rate of generation of drug resistant variants, and the appearance of microsatellite instability. Even low-level expression of this protein was sufficient to partially impair mismatch repair. The results suggest that this region is important to the ability of the mismatch repair system to mediate drug sensitivity and to maintain genomic stability.
- Published
- 2002
- Full Text
- View/download PDF
17. [First clinical experience with coronary endoscopy].
- Author
-
Hombach V, Höher M, Hannekum A, Hügel W, Buran B, Höpp HW, and Hirche H
- Subjects
- Cardiac Catheterization methods, Clinical Trials as Topic, Coronary Disease therapy, Fiber Optic Technology, Humans, Angioplasty, Balloon, Cardiac Catheterization instrumentation, Coronary Disease diagnosis, Endoscopes
- Abstract
In four different groups coronary endoscopy and endoscopy of peripheral vessels was carried out, using two ultrathin fibre endoscopes with a working length of 120 cm and a diameter of 1.4 or 1.8 mm. In a first series of seven cadaver hearts, normal vessels were found in three, one had high-grade stenosis and in the remaining three there were flat whitish atheromatous changes, rather scar-like in appearance. In a second series of 16 patients, the vascular wall in the iliac region was easily visualised in ten, while six showed diffuse atherosclerotic changes of the wall. In a third group of eight patients, coronary endoscopy was carried out at the time of balloon-catheter dilatation; endoscopy was successful in five patients. In two of them, the stenosis or occlusion to be dilated by balloon was visualised. In a fourth series, good visualisation of the vessels was obtained intraoperatively in seven out of nine patients, and in addition the course of the vessel distal to the stenosis as well as the site of anastomosis with the venous bypass graft could be seen. No serious side-effects of the procedure have yet been observed. Coronary endoscopy opens up a new dimension in the morphological assessment of coronary vascular changes. The method must, however, still be regarded as experimental.
- Published
- 1986
- Full Text
- View/download PDF
18. What's behind patient fear?
- Author
-
Buran B
- Subjects
- Adult, Child, Child Behavior, Female, Humans, Male, Memory, Dental Care psychology, Fear
- Published
- 1981
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.